Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

RNA-seq

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

Sanger Sequencing

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Publisher Correction: Clinical development of cancer vaccines.

Nature medicine·2026

Same author

Clinical development of cancer vaccines.

Nature medicine·2026

Same author

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

Nature communications·2026

Same author

Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Nature medicine·2025

Same author

Treatment of patients with pMMR GI cancers with tumor-infiltrating lymphocytes (TIL): a reality?

Trends in cancer·2025

Same author

Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Nature medicine·2025

Search research articles

Related Experiment Video

Updated: Nov 17, 2025

Laser Microdissection for Species-Agnostic Single-Tissue Applications

Laser Microdissection for Species-Agnostic Single-Tissue Applications

Published on: March 31, 2022

The power to "di-sc-seq-t".

Anne M van der Leun¹, John B Haanen²

¹Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands.

|February 12, 2021

Summary

This summary is machine-generated.

Talimogene laherparepvec (T-VEC) shows activity against cutaneous B cell lymphoma. This oncolytic immunotherapy replicates in tumor cells and other cells, stimulating an immune response against cancer.

More Related Videos

G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome

G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome

Published on: March 22, 2018

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

Published on: October 5, 2018

Related Experiment Videos

Last Updated: Nov 17, 2025

Laser Microdissection for Species-Agnostic Single-Tissue Applications

Laser Microdissection for Species-Agnostic Single-Tissue Applications

Published on: March 31, 2022

G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome

G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome

Published on: March 22, 2018

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

Published on: October 5, 2018

Area of Science:

Oncolytic virotherapy
Immunotherapy
Cancer research

Background:

Intratumoral talimogene laherparepvec (T-VEC) is an oncolytic immunotherapy primarily studied in melanoma.
Its mechanism is believed to involve viral replication, cancer cell lysis, and subsequent immune stimulation.

Purpose of the Study:

To investigate the efficacy of T-VEC in treating cutaneous B cell lymphoma.
To elucidate the cellular sites of T-VEC replication within the tumor microenvironment.

Main Methods:

Treatment of cutaneous B cell lymphoma models with T-VEC.
Single-cell RNA sequencing (scRNA-seq) to analyze viral replication patterns.

Main Results:

T-VEC demonstrated therapeutic activity in cutaneous B cell lymphoma.
scRNA-seq revealed that viral replication occurs not exclusively in tumor cells but also in other cellular components within the tumor microenvironment.

Conclusions:

T-VEC is a potential therapeutic agent for cutaneous B cell lymphoma.
The replication of T-VEC in non-tumor cells may contribute to its immunomodulatory effects in this cancer type.